Pregnant women advised to weigh risks of getting COVID vaccine, talk with their doctor - CBC.ca | Canada News Media
Connect with us

Health

Pregnant women advised to weigh risks of getting COVID vaccine, talk with their doctor – CBC.ca

Published

 on


A doctor at the IWK Health Centre in Halifax says pregnant women should talk with their doctors and weigh the risks of getting the COVID-19 vaccine given the lack of data available right now. 

Pregnant women were excluded from initial clinical trials for the Moderna and Pfizer-BioNTech vaccines, which means there’s no information about the safety and efficacy of the vaccine for them. 

Dr. Scott Halperin, director of the Canadian Centre for Vaccinology, said there’s no blanket recommendation telling Canadian women who are pregnant or breastfeeding not to get immunized, but “theoretical risks” should be considered.

“It’s really a case-by-case basis, individual decision of that risk,” he told CBC’s Information Morning on Thursday. “If somebody is not seen coming into contact with people with COVID-19 and they’re pregnant, they might be able to afford to wait several months and get the vaccine as soon as they deliver.”

Women working on the front lines of the pandemic may have different considerations, he added.

Information Morning – NS7:40COVID-19 vaccine while pregnant?

Not everyone is recommended for getting the COVID-19 vaccines, including pregnant people. Immunologist Dr. Scott Halperin tells us why. 7:40

“If somebody is in a position where they are much more likely to be exposed, then that individual risk might be more from the COVID-19 and a woman might choose to get the vaccine during pregnancy, and we’re seeing both of those situations and both of those different types of decisions,” Halperin said.

Early research released in December from the University of British Columbia shows that pregnant women are at higher risk of being hospitalized if they do get the virus compared to non-pregnant women in the same age group.

Researchers cautioned that their study is preliminary and only included data from cases in B.C., Alberta and Ontario.

Data could be available later this year

Halperin said at this point there are no red flags that the COVID vaccines themselves are harmful to a mother and baby.

The National Advisory Committee on Immunization, which provides advice to the federal government, recommends that approved COVID-19 vaccines may be provided to people excluded from clinical trials, “if a risk assessment deems that the benefits of vaccination outweigh the potential risks for the individual.”

“The biggest risk is if somebody, a woman, had a fever with the vaccine, which you can get and if it were a high fever, fever itself can be harmful, not all the time, but occasionally to the fetus, so it’s that type of risk that we’re looking at,” Halperin said. 

That could be a small risk compared to the risk of getting COVID-19, he added.

Dr. Scott Halperin is director of the Canadian Center for Vaccinology and head of pediatric infectious diseases at the IWK Health Centre. (Brooklyn Currie/CBC)

Halperin estimates it could still be six to eight months before data about how pregnant and breastfeeding women respond to the vaccine is available.

“There are women who are getting the vaccine and we’ll be collecting data from women who do receive the vaccine in order to see how they respond to the vaccine and to ensure that it is safe,” he said. 

Halperin advises women trying to get pregnant to take a similar approach and weigh the risks.

“If one gets the vaccine, one should wait about a month or six weeks before getting pregnant … even theoretically there wouldn’t be lasting risks so one doesn’t have to not get pregnant for a year, just for a matter of weeks.” 

He said at one time pregnant women weren’t involved in clinical trials at all over concerns about harming the fetus. 

“That’s no longer considered to be ethically sound because we need to use vaccines in pregnant women, and therefore we need to get data from clinical trials from pregnant women, but they’re still excluded from the initial studies,” Halperin said. 

Studies involving pregnant women and children are only done once the vaccines are deemed safe for the general public, he said.

More vaccines on the horizon

People who are immunocompromised also weren’t part of the initial clinical trials for the vaccines, and Halperin said it’s a good idea for them to talk with their health-care providers about the risks of getting immunized. 

“Right now, there are very few exclusions to getting vaccinated,” he said. “People who have had anaphylactic reactions to vaccines in the past … should take care with immunizing.”

Halperin said more vaccines will be available to Nova Scotians in the months ahead. The U.K. was the first country to approve the new AstraZeneca-Oxford vaccine and Halperin expects Canada won’t be far behind.

“Hopefully within a month or so, we’ll have maybe four vaccines and further ones a couple of months beyond that.”

MORE TOP STORIES

Let’s block ads! (Why?)



Source link

Continue Reading

Health

Canada to donate up to 200,000 vaccine doses to combat mpox outbreaks in Africa

Published

 on

 

The Canadian government says it will donate up to 200,000 vaccine doses to fight the mpox outbreak in Congo and other African countries.

It says the donated doses of Imvamune will come from Canada’s existing supply and will not affect the country’s preparedness for mpox cases in this country.

Minister of Health Mark Holland says the donation “will help to protect those in the most affected regions of Africa and will help prevent further spread of the virus.”

Dr. Madhukar Pai, Canada research chair in epidemiology and global health, says although the donation is welcome, it is a very small portion of the estimated 10 million vaccine doses needed to control the outbreak.

Vaccine donations from wealthier countries have only recently started arriving in Africa, almost a month after the World Health Organization declared the mpox outbreak a public health emergency of international concern.

A few days after the declaration in August, Global Affairs Canada announced a contribution of $1 million for mpox surveillance, diagnostic tools, research and community awareness in Africa.

On Thursday, the Africa Centres for Disease Control and Prevention said mpox is still on the rise and that testing rates are “insufficient” across the continent.

Jason Kindrachuk, Canada research chair in emerging viruses at the University of Manitoba, said donating vaccines, in addition to supporting surveillance and diagnostic tests, is “massively important.”

But Kindrachuk, who has worked on the ground in Congo during the epidemic, also said that the international response to the mpox outbreak is “better late than never (but) better never late.”

“It would have been fantastic for us globally to not be in this position by having provided doses a much, much longer time prior than when we are,” he said, noting that the outbreak of clade I mpox in Congo started in early 2023.

Clade II mpox, endemic in regions of West Africa, came to the world’s attention even earlier — in 2022 — as that strain of virus spread to other countries, including Canada.

Two doses are recommended for mpox vaccination, so the donation may only benefit 100,000 people, Pai said.

Pai questioned whether Canada is contributing enough, as the federal government hasn’t said what percentage of its mpox vaccine stockpile it is donating.

“Small donations are simply not going to help end this crisis. We need to show greater solidarity and support,” he said in an email.

“That is the biggest lesson from the COVID-19 pandemic — our collective safety is tied with that of other nations.”

This report by The Canadian Press was first published Sept. 13, 2024.

Canadian Press health coverage receives support through a partnership with the Canadian Medical Association. CP is solely responsible for this content.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Health

How many Nova Scotians are on the doctor wait-list? Number hit 160,000 in June

Published

 on

 

HALIFAX – The Nova Scotia government says it could be months before it reveals how many people are on the wait-list for a family doctor.

The head of the province’s health authority told reporters Wednesday that the government won’t release updated data until the 160,000 people who were on the wait-list in June are contacted to verify whether they still need primary care.

Karen Oldfield said Nova Scotia Health is working on validating the primary care wait-list data before posting new numbers, and that work may take a matter of months. The most recent public wait-list figures are from June 1, when 160,234 people, or about 16 per cent of the population, were on it.

“It’s going to take time to make 160,000 calls,” Oldfield said. “We are not talking weeks, we are talking months.”

The interim CEO and president of Nova Scotia Health said people on the list are being asked where they live, whether they still need a family doctor, and to give an update on their health.

A spokesperson with the province’s Health Department says the government and its health authority are “working hard” to turn the wait-list registry into a useful tool, adding that the data will be shared once it is validated.

Nova Scotia’s NDP are calling on Premier Tim Houston to immediately release statistics on how many people are looking for a family doctor. On Tuesday, the NDP introduced a bill that would require the health minister to make the number public every month.

“It is unacceptable for the list to be more than three months out of date,” NDP Leader Claudia Chender said Tuesday.

Chender said releasing this data regularly is vital so Nova Scotians can track the government’s progress on its main 2021 campaign promise: fixing health care.

The number of people in need of a family doctor has more than doubled between the 2021 summer election campaign and June 2024. Since September 2021 about 300 doctors have been added to the provincial health system, the Health Department said.

“We’ll know if Tim Houston is keeping his 2021 election promise to fix health care when Nova Scotians are attached to primary care,” Chender said.

This report by The Canadian Press was first published Sept. 11, 2024.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Health

Newfoundland and Labrador monitoring rise in whooping cough cases: medical officer

Published

 on

 

ST. JOHN’S, N.L. – Newfoundland and Labrador‘s chief medical officer is monitoring the rise of whooping cough infections across the province as cases of the highly contagious disease continue to grow across Canada.

Dr. Janice Fitzgerald says that so far this year, the province has recorded 230 confirmed cases of the vaccine-preventable respiratory tract infection, also known as pertussis.

Late last month, Quebec reported more than 11,000 cases during the same time period, while Ontario counted 470 cases, well above the five-year average of 98. In Quebec, the majority of patients are between the ages of 10 and 14.

Meanwhile, New Brunswick has declared a whooping cough outbreak across the province. A total of 141 cases were reported by last month, exceeding the five-year average of 34.

The disease can lead to severe complications among vulnerable populations including infants, who are at the highest risk of suffering from complications like pneumonia and seizures. Symptoms may start with a runny nose, mild fever and cough, then progress to severe coughing accompanied by a distinctive “whooping” sound during inhalation.

“The public, especially pregnant people and those in close contact with infants, are encouraged to be aware of symptoms related to pertussis and to ensure vaccinations are up to date,” Newfoundland and Labrador’s Health Department said in a statement.

Whooping cough can be treated with antibiotics, but vaccination is the most effective way to control the spread of the disease. As a result, the province has expanded immunization efforts this school year. While booster doses are already offered in Grade 9, the vaccine is now being offered to Grade 8 students as well.

Public health officials say whooping cough is a cyclical disease that increases every two to five or six years.

Meanwhile, New Brunswick’s acting chief medical officer of health expects the current case count to get worse before tapering off.

A rise in whooping cough cases has also been reported in the United States and elsewhere. The Pan American Health Organization issued an alert in July encouraging countries to ramp up their surveillance and vaccination coverage.

This report by The Canadian Press was first published Sept. 10, 2024.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending

Exit mobile version